Options like cucumbers and watermelon offer both water content and refreshment, and chances are, youll feel great afterward
This review seeks to systematically elucidate the relationship between GLP-1RAs and cancer risk, along with the potential underlying mechanisms involved
But that could soon change
In clinical practice, this effect is generally modest and does not significantly compromise antibiotic efficacy
Abstract Recent large clinical trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, with the aim of verifying cardiovascular safety, have revealed that these medications have a preventative advantage on adverse cardiovascular outcomes, including worsening of heart failure and deterioration of nephropathy, in patients with type 2 diabetes (T2D)
Here are common microdose calculations at a 5 mg/mL concentration: 0.5 mg dose: (0.5 / 5.0) x 100 = 10 units 0.75 mg dose: (0.75 / 5.0) x 100 = 15 units 1.0 mg dose: (1.0 / 5.0) x 100 = 20 units 1.25 mg dose: (1.25 / 5.0) x 100 = 25 units 1.5 mg dose: (1.5 / 5.0) x 100 = 30 units 2.0 mg dose: (2.0 / 5.0) x 100 = 40 units 2.5 mg dose: (2.5 / 5.0) x 100 = 50 units At a 10 mg/mL concentration, those same doses require half the volume